HP_A_217569 53..63
暂无分享,去创建一个
S. Parthasarathy | Jesse D. Martinez | Nathan W. Sweeney | Cecil J. Gomes | R. D. Armond | Sara M Centuori | Richard L. De Armond
[1] Yihai Cao. Adipocyte and lipid metabolism in cancer drug resistance. , 2019, The Journal of clinical investigation.
[2] Stephen Marchant,et al. Intraperitoneal injections as an alternative method for micro-CT contrast enhanced detection of murine liver tumors. , 2019, BioTechniques.
[3] Yihai Cao,et al. Cancer Lipid Metabolism Confers Antiangiogenic Drug Resistance. , 2018, Cell metabolism.
[4] A. Kraft,et al. Hypoxia-Inducible PIM Kinase Expression Promotes Resistance to Antiangiogenic Agents , 2017, Clinical Cancer Research.
[5] C. Cho,et al. Accelerated tumor growth under intermittent hypoxia is associated with hypoxia-inducible factor-1-dependent adaptive responses to hypoxia. , 2017, Oncotarget.
[6] V. Polotsky,et al. Hepatocyte Hypoxia Inducible Factor-1 Mediates the Development of Liver Fibrosis in a Mouse Model of Nonalcoholic Fatty Liver Disease , 2016, PloS one.
[7] L. Adams,et al. International Journal of Molecular Sciences the Natural Course of Non-alcoholic Fatty Liver Disease , 2022 .
[8] Hypoxia-inducible factors as molecular targets for liver diseases , 2016, Journal of Molecular Medicine.
[9] Ahmedin Jemal,et al. Global Cancer Incidence and Mortality Rates and Trends—An Update , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[10] A. Malhotra,et al. Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology , 2015, Digestive Diseases and Sciences.
[11] I. Benseñor,et al. Effects of CPAP on body weight in patients with obstructive sleep apnoea: a meta-analysis of randomised trials , 2014, Thorax.
[12] S. Shinjo,et al. Hypoxia and fatty liver. , 2014, World journal of gastroenterology.
[13] D. Clegg,et al. Ascent to altitude as a weight loss method: The good and bad of hypoxia inducible factor activation , 2014, Obesity.
[14] R. Farré,et al. Association between obstructive sleep apnea and cancer incidence in a large multicenter Spanish cohort. , 2013, American journal of respiratory and critical care medicine.
[15] S. Bhanot,et al. Metabolic Consequences of High-Fat Diet Are Attenuated by Suppression of HIF-1α , 2012, PloS one.
[16] B. Krock,et al. Hypoxia-induced angiogenesis: good and evil. , 2011, Genes & cancer.
[17] 竹原 徹郎,et al. Liver, Pancreas, and Biliary Tract ヒト化マウスモデルを用いたC型肝炎ウイルスによる感染、免疫応答、肝病態形成の解析 , 2011 .
[18] Jianguo Li,et al. Intermittent Hypoxia Exacerbates Metabolic Effects of Diet‐Induced Obesity , 2011, Obesity.
[19] K. Basen-Engquist,et al. Obesity and Cancer Risk: Recent Review and Evidence , 2011, Current oncology reports.
[20] J. Ward,et al. Proliferative and Nonproliferative Lesions of the Rat and Mouse Hepatobiliary System , 2010, Toxicologic pathology.
[21] Rainald Fischer,et al. Hypobaric Hypoxia Causes Body Weight Reduction in Obese Subjects , 2010, Obesity.
[22] S. Klein,et al. Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications , 2010, Hepatology.
[23] A. Feldstein,et al. Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal , 2009, Expert review of gastroenterology & hepatology.
[24] M. Kryger,et al. Epidemiology of obstructive sleep apnea: a population-based perspective , 2008, Expert review of respiratory medicine.
[25] Geng-Wen Huang,et al. Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival. , 2005 .
[26] Michael J Thun,et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.
[27] Johan Bussink,et al. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. , 2002, Cancer research.
[28] M. Lerman,et al. Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. , 2001, Cancer research.
[29] J. Dixon,et al. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. , 2001, Gastroenterology.
[30] C. Weghorst,et al. Dose-Response Relationship of Diethylnitrosamine-Initiated Tumors in Neonatal Balb/c Mice: Effect of Phenobarbital Promotion , 1988, Toxicologic pathology.